Form 4 for NHC NATIONAL HEALTHCARE CORP
Accepted 2025-06-16 00:00:00 ET · period of report 2025-06-12 · accession 0001437749-25-020500 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2025-06-16 | 2025-06-12 | NHC | Dodson Vicki L | Sr.VP Patient Srvcs | M - OptEx | $58.95 | +7,467 | 11.3K | +196% | +$440.2K |
| DM | 2025-06-16 | 2025-06-12 | NHC | Dodson Vicki L | Sr.VP Patient Srvcs | F - Tax | $104.56 | -5,265 | 9,749 | -35% | -$550.5K |
| DM | 2025-06-16 | 2025-06-12 | NHC | Dodson Vicki L | Sr.VP Patient Srvcs | M - OptEx | $0.00 | -7,467 | 0 | -100% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Shares of Common Stock held in my name | 2025-06-12 | M | A | 3,734 | $63.96 | 12,502.55 | D | — | — | (F3) These stock options were granted pursuant to the 2020 Omnibus Equity Incentive Plan on February 18, 2022. The grant and exercise of these stock options are exempt from Section 16(b) pursuant to Rule 16b-3(d). |
| 2 | Common | Shares of Common Stock held in my name | 2025-06-12 | F | D | 2,511 | $104.56 | 8,768.55 | D | — | — | (F2) Shares were withheld by the Company to pay the exercise price and withholding tax obligations. |
| 3 | Common | Shares of Common Stock held in my name | 2025-06-12 | M | A | 3,733 | $53.94 | 11,279.55 | D | — | — | (F1) These stock options were granted pursuant to the 2020 Omnibus Equity Incentive Plan on March 8, 2023. The grant and exercise of these stock options are exempt from Section 16(b) pursuant to Rule 16b-3(d). |
| 4 | Common | Shares of Common Stock held in my name | 2025-06-12 | F | D | 2,754 | $104.56 | 9,748.55 | D | — | — | (F2) Shares were withheld by the Company to pay the exercise price and withholding tax obligations. (F4) Total amount of shares beneficially owned following transactions reported for this Title of Securities on this form. |
| 5 | Derivative | Option to Purchase Common Stock | 2025-06-12 | M | D | 3,733 | $0.00 | 3,734 | D | $53.94 · 2024-03-08 to 2028-03-08 | 7,467 Common Stock | (F1) These stock options were granted pursuant to the 2020 Omnibus Equity Incentive Plan on March 8, 2023. The grant and exercise of these stock options are exempt from Section 16(b) pursuant to Rule 16b-3(d). |
| 6 | Derivative | Option to Purchase Common Stock | 2025-06-12 | M | D | 3,734 | $0.00 | 0 | D | $63.96 · 2023-02-18 to 2027-02-18 | 3,734 Common Stock | (F3) These stock options were granted pursuant to the 2020 Omnibus Equity Incentive Plan on February 18, 2022. The grant and exercise of these stock options are exempt from Section 16(b) pursuant to Rule 16b-3(d). |